{"id":939387,"date":"2026-02-24T08:25:52","date_gmt":"2026-02-24T13:25:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/"},"modified":"2026-02-24T08:25:52","modified_gmt":"2026-02-24T13:25:52","slug":"holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/","title":{"rendered":"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, Feb.  24, 2026  (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Mereo BioPharma Group plc (\u201cMereo\u201d or the \u201cCompany\u201d) (NASDAQ: MREO). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts, including allegations that Defendants concealed and misrepresented facts regarding setrusumab\u2019s ability to achieve statistical significance for the primary endpoints in both the ORBIT and COSMIC studies.<\/p>\n<p align=\"justify\">If you purchased Mereo shares between <strong>June 5, 2023 and December 26, 2025<\/strong>, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c7NfCC7i9G2xn1sHwukSGhCKtHUcOLpDRsH4puYjSMBcq56HhDW7JHLtotc-WMvP-dqucbVrE9IWPYZLCuihAnAb8H4xxtetbHqigcIlbpo=\" rel=\"nofollow\" target=\"_blank\"><u>cholzer@holzerlaw.com<\/u><\/a>, by toll-free telephone at (888) 508-6832, or by visiting the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=THbj_xsfq96S87rrm9_27bxWFHZRKRZgvHzt6F-EzYojzp4MYrpjn7urMqw-DRTbyRWJ9MX2y8O0nHecv3Itgsp-QFA4cRfBF-DKkuiPMzmutQ7JH3kl9ZZR4vW3QXj5tsjPic7NxzyPudzFEJppTIQhqX3IgsNQ5LYNdUdbSCY=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/mereo-biopharma-group\/<\/a> for more information.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is\u00a0April 6, 2026.<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website,\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=THbj_xsfq96S87rrm9_27YbXmejffn0pflXwNH39VEV7Hn5nrs9oxERvoepkmEvEKclW4PEZM59DcFslHU1PRoTKrLGi_ZxzcI-N684zhJs=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c7NfCC7i9G2xn1sHwukSGhCKtHUcOLpDRsH4puYjSMDb6Byt4cndSYxBcODSQb5vMfWHE3_MMdcVFDKoJ3drgLxdONDGLxVSCcvdfDu3uyI=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2I4ZmZmMDQtYjhkNS00YmY3LTgxMmQtNzdjZTliMTI2NmQ5LTExOTIzMzYtMjAyNi0wMi0yNC1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Mereo BioPharma Group plc (\u201cMereo\u201d or the \u201cCompany\u201d) (NASDAQ: MREO). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts, including allegations that Defendants concealed and misrepresented facts regarding setrusumab\u2019s ability to achieve statistical significance for the primary endpoints in both the ORBIT and COSMIC studies. If you purchased Mereo shares between June 5, 2023 and December 26, 2025, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm\u2019s website at www.holzerlaw.com\/case\/mereo-biopharma-group\/ &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-939387","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Mereo BioPharma Group plc (\u201cMereo\u201d or the \u201cCompany\u201d) (NASDAQ: MREO). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts, including allegations that Defendants concealed and misrepresented facts regarding setrusumab\u2019s ability to achieve statistical significance for the primary endpoints in both the ORBIT and COSMIC studies. If you purchased Mereo shares between June 5, 2023 and December 26, 2025, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm\u2019s website at www.holzerlaw.com\/case\/mereo-biopharma-group\/ &hellip; Continue reading &quot;Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-24T13:25:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action\",\"datePublished\":\"2026-02-24T13:25:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/\",\"name\":\"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=\",\"datePublished\":\"2026-02-24T13:25:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/","og_locale":"en_US","og_type":"article","og_title":"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action - Market Newsdesk","og_description":"ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Mereo BioPharma Group plc (\u201cMereo\u201d or the \u201cCompany\u201d) (NASDAQ: MREO). The lawsuit alleges that Defendants issued false and misleading statements and\/or failed to disclose material adverse facts, including allegations that Defendants concealed and misrepresented facts regarding setrusumab\u2019s ability to achieve statistical significance for the primary endpoints in both the ORBIT and COSMIC studies. If you purchased Mereo shares between June 5, 2023 and December 26, 2025, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm\u2019s website at www.holzerlaw.com\/case\/mereo-biopharma-group\/ &hellip; Continue reading \"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-24T13:25:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action","datePublished":"2026-02-24T13:25:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/"},"wordCount":276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/","name":"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=","datePublished":"2026-02-24T13:25:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1OTQ4MiM3NDQ5NzkxIzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-mreo-investors-of-the-april-6-2026-lead-plaintiff-deadline-in-the-mereo-biopharma-group-plc-securities-class-action-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Holzer &amp; Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/939387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=939387"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/939387\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=939387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=939387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=939387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}